Table 2

Funding as declared in published cost-effectiveness analyses: acknowledgements/grants/affiliations

Funding source as stated
Author, PYRAcknowledgement (trial data, or not specified)Grant(Co-)Authors' affiliation, or ‘editorial assistance’, if other than academic institution/university/hospital
Bansback et al 200541AbbottAbbott: editorial assistance
Barbieri et al 200547Schering-Plough (research grant)Schering-Plough
Brennan et al 200445Wyeth
Brennan et al 200739Grant from the British Society for Rheumatology (BSR receives support from Abbott, Amgen, Schering-Plough, and Wyeth)
Chen et al200628Author previously received funding from Abbott and WyethFunded by the HTA Programme on behalf of NICE
Chiou et al 200442Cerner Corporation
Choi et al200055‘No specific source of support’
Choi et al 200220‘No specific financial support’
Clark et al 200456HTA
Davies et al 200932AbbottEmron, Abbott, JK Associates, Inc.: editorial assistance
Fautrel et al 200830 31 ABNS (AB)
Finckh et al 200921Arthritis foundation, anonymous donor
Gdovin Bergeson and Rosenblatt59 ABBristol-Myers Squibb
Jobanputra et al 200252Author engaged in a Wyeth-sponsored trialNHS/HTA (Commissioned by HTA Programme on behalf of NICE)
Kielhorn et al 200860Hoffmann-La RocheHoffmann-La Roche
Kobelt et al 200215NSStockholm Health Economics Consulting
Kobelt et al 200348Schering-Plough
Kobelt et al 200444Österlund/Kock Foundation, King Gustav V Fund, Reumatikerförbundet
Kobelt et al 200543WyethWyeth
Maetzel et al 200237Author consultant to AventisAventis
Marra et al 200746Canadian Arthritis Network
Payet 200761 77NS (AB)Hoffmann-La Roche77
Pompen et al 200762Hoffmann-La Roche
Russell et al 200966Bristol-Myers Squibb
Schädlich et al 200514AventisAventis
Spalding and Hay 200629Abbott (‘previously’)Astellas Pharma
Vera-Llonch et al 200857Bristol-Myers SquibbBristol-Myers Squibb
Vera-Llonch et al 200865Bristol-Myers SquibbBristol-Myers Squibb
Welsing et al 200436Wyeth trial data
Wailoo et al 200840NS
Wong et al 200249Schering-Plough
Yuan et al 200864 ABBristol-Myers Squibb
  • AB, published in abstract form only; HTA, Health Technology Assessment Report; NICE, National Institute for Health and Clinical Excellence; NS, not stated; PYR, year of publication.